Changzhou Qianhong Biopharma CO.,LTD (SHE:002550)
6.02
-0.19 (-3.06%)
Apr 25, 2025, 3:04 PM CST
SHE:002550 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 390.04 | 333.18 | 181.86 | 323.41 | 181.08 | -132.02 | Upgrade
|
Depreciation & Amortization | 65.49 | 65.49 | 67.19 | 64.76 | 69.43 | 70.25 | Upgrade
|
Other Amortization | 4.39 | 4.39 | 5.78 | 3.55 | 5.67 | 3.39 | Upgrade
|
Loss (Gain) From Sale of Assets | - | - | -25.35 | -57.59 | - | - | Upgrade
|
Asset Writedown & Restructuring Costs | -78.15 | -78.15 | 7.77 | 0.24 | 0.46 | 1.6 | Upgrade
|
Loss (Gain) From Sale of Investments | -11.53 | -11.53 | -8.83 | 3.82 | -0.64 | -16.03 | Upgrade
|
Provision & Write-off of Bad Debts | - | - | -19.02 | 15.3 | -52.68 | 5.04 | Upgrade
|
Other Operating Activities | -153.22 | 3.23 | 19.11 | -46.62 | 6.11 | 390.89 | Upgrade
|
Change in Accounts Receivable | -12.26 | -12.26 | 420.4 | -165.9 | 55.37 | 49.78 | Upgrade
|
Change in Inventory | 172.11 | 172.11 | -77.46 | -136.12 | -84.79 | -73.03 | Upgrade
|
Change in Accounts Payable | 24.09 | 24.09 | -50.63 | -83.14 | -86.65 | 82.57 | Upgrade
|
Change in Other Net Operating Assets | -0.62 | -0.62 | 1.98 | 4.37 | 4.12 | 4.07 | Upgrade
|
Operating Cash Flow | 415.11 | 514.71 | 533.33 | -71.47 | 103.56 | 317.28 | Upgrade
|
Operating Cash Flow Growth | -43.33% | -3.49% | - | - | -67.36% | 96.40% | Upgrade
|
Capital Expenditures | -103.72 | -90.64 | -100.33 | -70.99 | -90.37 | -62.53 | Upgrade
|
Sale of Property, Plant & Equipment | - | 13.5 | 32.3 | 0.11 | 0 | 0.02 | Upgrade
|
Cash Acquisitions | - | - | - | -1.67 | - | - | Upgrade
|
Investment in Securities | -80.27 | -80.27 | -108.5 | -121.08 | 177.22 | 489.88 | Upgrade
|
Other Investing Activities | -92.34 | -165.83 | 1.43 | 3.65 | 8.43 | 32.17 | Upgrade
|
Investing Cash Flow | -276.33 | -323.23 | -175.1 | -189.98 | 95.28 | 459.53 | Upgrade
|
Short-Term Debt Issued | - | - | 435.51 | 461.27 | 124.95 | 326.15 | Upgrade
|
Long-Term Debt Issued | - | 4.69 | - | - | - | - | Upgrade
|
Total Debt Issued | 4.69 | 4.69 | 435.51 | 461.27 | 124.95 | 326.15 | Upgrade
|
Short-Term Debt Repaid | - | - | -480 | -440 | -77.43 | -628.54 | Upgrade
|
Long-Term Debt Repaid | - | -40.1 | - | - | - | - | Upgrade
|
Total Debt Repaid | -40.1 | -40.1 | -480 | -440 | -77.43 | -628.54 | Upgrade
|
Net Debt Issued (Repaid) | -35.41 | -35.41 | -44.49 | 21.27 | 47.52 | -302.39 | Upgrade
|
Issuance of Common Stock | - | - | - | 144.9 | - | 171.84 | Upgrade
|
Repurchase of Common Stock | - | - | -30.09 | - | -0.19 | -0.3 | Upgrade
|
Common Dividends Paid | -152 | -151.52 | -158.79 | -155.16 | -151.51 | -313.62 | Upgrade
|
Other Financing Activities | 3 | -137.77 | 42.5 | - | - | - | Upgrade
|
Financing Cash Flow | -184.41 | -324.71 | -190.87 | 11.02 | -104.17 | -444.47 | Upgrade
|
Foreign Exchange Rate Adjustments | -0.07 | -1.85 | -1.6 | 41.89 | 7.39 | -18.6 | Upgrade
|
Net Cash Flow | -45.7 | -135.07 | 165.76 | -208.55 | 102.06 | 313.74 | Upgrade
|
Free Cash Flow | 311.39 | 424.07 | 433 | -142.46 | 13.19 | 254.74 | Upgrade
|
Free Cash Flow Growth | -51.20% | -2.06% | - | - | -94.82% | 318.51% | Upgrade
|
Free Cash Flow Margin | 20.54% | 27.79% | 23.87% | -6.18% | 0.70% | 15.28% | Upgrade
|
Free Cash Flow Per Share | 0.24 | 0.33 | 0.33 | -0.11 | 0.01 | 0.21 | Upgrade
|
Cash Income Tax Paid | 153.02 | 150.65 | 45.16 | 26.55 | 81.87 | 79.15 | Upgrade
|
Levered Free Cash Flow | -7.36 | 150.05 | 339.38 | -216.74 | -40.56 | 609.25 | Upgrade
|
Unlevered Free Cash Flow | -7.36 | 150.05 | 343.09 | -213.46 | -39.53 | 614.53 | Upgrade
|
Change in Net Working Capital | 163.51 | 13.24 | -272.06 | 354.27 | 123.62 | -468.1 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.